| Dr Ana Carolina Victoria, MD | |
|
7800 Sw 87th Ave, Suite A100, Miami, FL 33173-3570 | |
| (305) 273-7998 | |
| Not Available |
| Full Name | Dr Ana Carolina Victoria |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 17 Years |
| Location | 7800 Sw 87th Ave, Miami, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114217551 | NPI | - | NPPES |
| 014702400 | Medicaid | FL |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Excellence In Eyecare Pa | 0345269148 | 17 |
News Archive
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
The first lawsuit against a trucking company acknowledging that sleep apnea played a role in a highway death reached a settlement last week. A Texas family was awarded over $3 million dollars after a driver rear-ended John Lindsay's vehicle on a Texas interstate in May of 2010. Evidence showed that the driver had refused to treat his previously diagnosed sleep apnea and the company did not ensure follow up care was provided.
› Verified 4 days ago
| Entity Name | Vitalmd Group Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871572032 PECOS PAC ID: 8921091786 Enrollment ID: O20040406001878 |
News Archive
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
The first lawsuit against a trucking company acknowledging that sleep apnea played a role in a highway death reached a settlement last week. A Texas family was awarded over $3 million dollars after a driver rear-ended John Lindsay's vehicle on a Texas interstate in May of 2010. Evidence showed that the driver had refused to treat his previously diagnosed sleep apnea and the company did not ensure follow up care was provided.
› Verified 4 days ago
| Entity Name | Center For Excellence In Eyecare Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043227176 PECOS PAC ID: 0345269148 Enrollment ID: O20051121000844 |
News Archive
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
The first lawsuit against a trucking company acknowledging that sleep apnea played a role in a highway death reached a settlement last week. A Texas family was awarded over $3 million dollars after a driver rear-ended John Lindsay's vehicle on a Texas interstate in May of 2010. Evidence showed that the driver had refused to treat his previously diagnosed sleep apnea and the company did not ensure follow up care was provided.
› Verified 4 days ago
| Entity Name | Thrive Health Iv Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083314785 PECOS PAC ID: 0941668057 Enrollment ID: O20230907003065 |
News Archive
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
The first lawsuit against a trucking company acknowledging that sleep apnea played a role in a highway death reached a settlement last week. A Texas family was awarded over $3 million dollars after a driver rear-ended John Lindsay's vehicle on a Texas interstate in May of 2010. Evidence showed that the driver had refused to treat his previously diagnosed sleep apnea and the company did not ensure follow up care was provided.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ana Carolina Victoria, MD 7001sw 97th Ave, Suite 101, Miami, FL 33173-3570 Ph: (305) 273-7998 | Dr Ana Carolina Victoria, MD 7800 Sw 87th Ave, Suite A100, Miami, FL 33173-3570 Ph: (305) 273-7998 |
News Archive
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
The first lawsuit against a trucking company acknowledging that sleep apnea played a role in a highway death reached a settlement last week. A Texas family was awarded over $3 million dollars after a driver rear-ended John Lindsay's vehicle on a Texas interstate in May of 2010. Evidence showed that the driver had refused to treat his previously diagnosed sleep apnea and the company did not ensure follow up care was provided.
› Verified 4 days ago
Efrem D Mandelcorn, ND Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 900 Nw 17th St, Miami, FL 33136 Phone: 305-326-6000 Fax: 605-547-3713 | |
Zelia Maria Correa, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Nw 17th St, Miami, FL 33136 Phone: 305-326-6000 | |
Dr. Fernando Lopez, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1097 Sw 42nd Ave Fl 3, Miami, FL 33134 Phone: 305-442-2020 | |
Dr. Kendall E Donaldson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Nw 17th Ave, Miami, FL 33101 Phone: 305-326-6031 Fax: 305-243-8470 | |
Dr. Richard K Forster, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Nw 17th Ave, Box 016960 M851, Miami, FL 33101 Phone: 305-326-6031 Fax: 305-243-8470 | |
Ta Chen Peter Chang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Nw 17th St, Miami, FL 33136 Phone: 305-243-2020 Fax: 305-326-6306 | |
Lily Zhang, Ophthalmology Medicare: Medicare Enrolled Practice Location: 1611 Nw 12th Ave, Miami, FL 33136 Phone: 305-326-6391 |